WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,700.00
+150.00 (2.29%)
At close: Dec 5, 2025
6.01%
Market Cap 88.45B
Revenue (ttm) 102.11B
Net Income (ttm) 6.26B
Shares Out 13.20M
EPS (ttm) 473.38
PE Ratio 14.15
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 53,115
Average Volume 38,893
Open 6,640.00
Previous Close 6,550.00
Day's Range 6,560.00 - 6,740.00
52-Week Range 5,610.00 - 10,450.00
Beta 0.71
RSI 55.04
Earnings Date n/a

About KOSDAQ:330350

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name... [Read more]

Industry Pharmaceutical Preparations
Founded 2004
Employees 121
Stock Exchange KOSDAQ
Ticker Symbol 330350
Full Company Profile

Financial Performance

In 2024, KOSDAQ:330350's revenue was 102.72 billion, an increase of 28.21% compared to the previous year's 80.12 billion. Earnings were 4.78 billion, a decrease of -39.88%.

Financial Statements

News

There is no news available yet.